CMP-002 — Topline data
H1 2028
The Company is targeting a topline data readout from the ASCEND clinical trial in the first half of 2028.Source filing
CAMP biotech catalysts & pipeline
CAMP4 THERAPEUTICS CORP · Data as of 2026-10-25
catalyst calendar
/